- Home
- IVT vs HTFL Comparison
IVT vs HTFL Comparison
Compare IVT & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IVT | HTFL |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | IVT | HTFL |
|---|---|---|
| Price | $35.38 | $26.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $32.50 | ★ $38.20 |
| AVG Volume (30 Days) | 1.5M | ★ 2.2M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 647.37 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $299,169,000.00 | N/A |
| Revenue This Year | $8.42 | $27.66 |
| Revenue Next Year | $5.25 | $23.55 |
| P/E Ratio | $507.00 | ★ N/A |
| Revenue Growth | ★ 9.20 | N/A |
| 52 Week Low | $26.65 | $20.13 |
| 52 Week High | $36.27 | $41.22 |
Technical Indicators
Market Signals| Indicator | IVT | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 58.88 | 35.69 |
| Support Level | $33.84 | $24.77 |
| Resistance Level | $36.15 | $32.69 |
| Average True Range (ATR) | 0.64 | 2.27 |
| MACD | -0.07 | -0.95 |
| Stochastic Oscillator | 67.90 | 3.28 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.